PDCD1 and neoplasm: Moreover, the finding that combined blockade of PD-L1 and IL10 further enhanced T-cell immunity 50, 51 suggests that IL13 may also have the potential to be targeted together with PD-1/PD-L1 to increase anti-tumor function.